<DOC>
	<DOCNO>NCT01676311</DOCNO>
	<brief_summary>We explore use Huperzine A patient sustained moderate severe Traumatic Brain Injury . We aim determine whether Huperzine A , compare placebo , would effect memory function TBI . Additionally , aim determine whether use Huperzine A patient change brain activity ( indexed EEG Transcranial Magnetic Stimulation - TMS ) , reduce prevalence/frequency post-traumatic seizure . We also aim evaluate safety Huperzine A population compare placebo .</brief_summary>
	<brief_title>Effects Huperzine A Treatment Moderate Severe TBI</brief_title>
	<detailed_description />
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Huperzine A</mesh_term>
	<criteria>Males female age 18 65 Moderate severe TBI , base admission Emergency Room GCS 312 All subject great 2 week , 1 year , qualify TBI , symptomatic enrollment ( i.e . subject exhibit evidence ongoing posttraumatic amnesia via Galveston Orientation Amnesia test ( GOAT ) , score least 1.5 SD mean completion time Part B Trail Making Test . Agreement undergo change concomitant medication ( include dietary supplement ) therapeutic intervention first 12 week study ( , 12 week dose study drug ) , except medically indicate . Stable concomitant drug regimen ( great two week preenrollment without change ) Normal swallow Englishspeaking ( since outcome metric normed outside English language ) Patient seizure medication . Patients take acetylcholinesterase inhibitor cholinergic anticholinergic drug ( e.g. , tacrine , physostigmine , velnacrine , donepezil , rivastigmine , metrifonate ) CYP1A induce drug . Evidence 1 seizure past 4 week prior enrollment : Patients may enrol evidence one seizure ( clinical electrographic , include epileptiform irritative discharge ) 4 week prior enrollment . Premorbid history epilepsy seizure frequency &gt; 1 per month : Patients history idiopathic epilepsy may enrol seizure frequency &gt; 1 per month 3 month prior injury . If preinjury seizure frequency &lt; 1 per month document evidence postinjury seizure frequency &gt; 1 per month document evidence increase severity duration single seizure relative premorbid history , patient must exclude . Evidence premorbid major CNS disorder , developmental disorder , psychiatric disorder substance abuse : Prior sustain TBI , patient diagnose and/or treated major neurologic condition , pervasive developmental disorder ( e.g. , mental retardation , autism ) , psychiatric disorder substance abuse continue produce functional disability time injury . Individuals disorder consciousness , define time screen vegetative and/or minimally conscious state , enrol . However , patient may follow : Meet eligibility criterion Are 12 week post injury Are discharged Pregnancy , determine urine hCG test randomization Breast feeding female Significant hematologic , renal hepatic dysfunction [ Hepatic/renal dysfunction generally identify lab result &gt; two time upper limit normal ( ULN ) , hematologic dysfunction determine clinically significant abnormal lab result ] , baseline laboratory examination . Slow heart rate ( bradycardia ) heart condition related rate History peptic ulcer disease History asthma emphysema History GI/urinary tract blockage ( i.e . ileus , IBS ) History glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>cognition</keyword>
	<keyword>seizure</keyword>
	<keyword>electroencephalography</keyword>
	<keyword>transcranial magnetic stimulation</keyword>
	<keyword>huperzine</keyword>
	<keyword>chinese club moss</keyword>
</DOC>